Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Tumors in Adolescents and Young Adults

Editor(s): Stark D.P. (Leeds) 
Vassal G. (Villejuif) 
Cover

Cross-Cutting Issues

Epidemiology of Adolescents and Young Adults with Cancer in Europe

Desandes E.a, b · Stark D.P.c

Author affiliations

aRegistre National des Tumeurs Solides de l'Enfant, CHU Nancy, Vandoeuvre-lès-Nancy, and bRegistre National des Cancers de l'Enfant, CRESS équipe 7, Inserm UMRS-1153, Université Paris-Sorbonne, Paris, France; cInstitute of Cancer and Pathology, St. James's University Hospital, University of Leeds, Leeds, UK

Related Articles for ""

Stark DP, Vassal G (eds): Tumors in Adolescents and Young Adults. Prog Tumor Res. Basel, Karger, 2016, vol 43, pp 1-15

Do you have an account?

Login Information





Contact Information











I have read the Karger Terms and Conditions and agree.



Login Information





Contact Information











I have read the Karger Terms and Conditions and agree.



To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.
Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00


Select

Complete book

  • Immediate access to all parts of this book
  • Cover-to-cover formats may be available
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restriction for personal use
read more

Pricing depends on hard-cover price


Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Cross-Cutting Issues

Published online: September 05, 2016
Cover Date: 2016

Number of Print Pages: 15
Number of Figures: 6
Number of Tables: 6

ISBN: 978-3-318-05911-3 (Print)
eISBN: 978-3-318-05912-0 (Online)

Abstract

To design the services for adolescents and young adults (AYAs) with cancer, we need to understand the patterns of disease and the other clinical and managerial challenges of the patient group. Cancer occurring between the ages of 15 and 39 years is 4 times less rare than cancer occurring during the first 15 years of life and consists of 2% of all invasive cancer in Europe, about 66,000 patients in Europe each year. AYAs have a unique distribution of cancer types, including the peak in incidence of Hodgkin lymphoma (HL) or germ cell tumors. The relative improvement in the survival rate in AYAs has not kept pace with that achieved in younger children, especially for acute leukemia, non-HLs, Ewing tumors and rhabdomyosarcoma. Etiological factors are under-researched and remain largely hypothetical. In this unique group of illnesses, improving AYA cancer management involves bridging interfaces. Since this has begun, outcomes have also begun to improve. The local nature of these interfaces determines the age group considered as AYA. Specific skills are necessary in the clinical, biological and psychosocial domains. Services need support from policy, clinical and administrative professionals. National policy and supranational groups such as SIOPE and ESMO are in constructive collaboration to develop this further.

© 2016 S. Karger AG, Basel


References

  1. Stark D, Bielack S, Brugieres L, Dirksen U, Duarte X, Dunn S, et al: Teenagers and young adults with cancer in Europe: from national programmes to a European integrated coordinated project. Eur J Cancer Care (Engl) 2016;25:419-427.
  2. Eurostat - Your Key for European Statistics. http://ec.europa.eu/eurostat/web/population-demography-migration-projections/population-data (accessed December 11, 2015).
  3. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, et al: Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013;49:1374-1403.
  4. World Health Organization - Health Topics. http://www.euro.who.int/en/health-topics (accessed December 11, 2015).
  5. Tyczynski JE, Demaret E, Parkin M: Standards and Guidelines for Cancer Registration in Europe: The ENCR Recommendations. Lyon, IARC Technical Publication, 2003.
  6. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, et al (eds): International Classification of Diseases for Oncology. Geneva, World Health Organization, 2000.
  7. Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P: International classification of childhood cancer, third edition. Cancer 2005;103:1457-1467.
  8. Birch JM, Alston RD, Kelsey AM, Quinn MJ, Babb P, McNally RJ: Classification and incidence of cancers in adolescents and young adults in England 1979-1997. Br J Cancer 2002;87:1267-1274.
  9. Desandes E, Lacour B, Sommelet D, Buemi A, Danzon A, Delafosse P, et al: Cancer incidence among adolescents in France. Pediatr Blood Cancer 2004;43:742-748.
  10. Steliarova-Foucher E, O'Callaghan M, Ferlay J, Masuyer E, Rosso S, Forman D, et al: The European cancer observatory: a new data resource. Eur J Cancer 2015;51:1131-1143. Accessed on August 3, 2016, at http://eco.iarc.fr.
  11. Forman D, Bray F, Brewster DH, Gombe Mbalawa C, Kohler B, Piñeros M, et al: Cancer Incidence in Five Continents Volume X. Lyon, IARC Scientific Publication, No. 164, 2013.
  12. Bleyer A, Viny A, Barr R: Cancer in 15- to 29-year-olds by primary site. Oncologist 2006;11:590-601.
  13. Trama A, Botta L, Foschi R, Ferrari A, Stiller C, Desandes E, et al: Survival of European adolescents and young adults diagnosed with cancer in 2000-2007: population-based data from EUROCARE-5. Lancet Oncol 2016;pii:S1470-S2045(16)00162-5.
  14. Lewis IJ: Cancer in adolescence. Br Med Bull 1996;52:887-897.
  15. Birch JM, Bleyer A: Epidemiology and etiology of cancer in adolescents and young adults; in Bleyer A, Barr RD (eds): Cancer in Adolescents and Young Adults. Berlin, Springer Berlin Heidelberg, 2007, pp 39-59.
  16. Mirabello L, Troisi RJ, Savage SA: Osteosarcoma incidence and survival rates from 1973 to 2004: data from the surveillance, epidemiology, and end results program. Cancer 2009;115:1531-1543.
  17. Michelagnoli MP, Pritchard J, Phillips MB: Adolescent oncology - a homeland for the ‘lost tribe'. Eur J Cancer 2003;39:2571-2572.
  18. Rugbjerg K, Mellemkjaer L, Boice JD, Kober L, Ewertz M, Olsen JH: Cardiovascular disease in survivors of adolescent and young adult cancer: a Danish cohort study, 1943-2009. J Natl Cancer Inst 2014;106:dju110.
  19. Rugbjerg K, Olsen JH: Long-term risk of hospitalization for somatic diseases in survivors of adolescent or young adult cancer. JAMA Oncol 2016;2:193-200.
  20. Woodward E, Jessop M, Glaser A, Stark D: Late effects in survivors of teenage and young adult cancer: does age matter? Ann Oncol 2011;22:2561-2568.
  21. World Health Organisation: Adolescent development. 2015. http://www.who.int/maternal_child_adolescent/topics/adolescence/dev/en/.
  22. Arnett JJ: Emerging adulthood. A theory of development from the late teens through the twenties. Am Psychol 2000;55:469-480.
  23. Potosky AL, Harlan LC, Albritton K, Cress RD, Friedman DL, Hamilton AS, et al; AYA HOPE Study Collaborative Group: Use of appropriate initial treatment among adolescents and young adults with cancer. J Natl Cancer Inst 2014;106:pii:dju300.
  24. Birch JM, Alston RD, Kelsey AM, Quinn MJ, Babb P, McNally RJ: Classification and incidence of cancers in adolescents and young adults in England 1979-1997. Br J Cancer 2002;87:1267-1274.
  25. Bleyer A, Barr R, Hayes-Lattin B, Thomas D, Ellis C, Anderson B; Biology and Clinical Trials Subgroups of the US National Cancer Institute Progress Review Group in Adolescent and Young Adult Oncology: The distinctive biology of cancer in adolescents and young adults. Nat Rev Cancer 2008;8:288-298.
  26. Veal GJ, Hartford CM, Stewart CF: Clinical pharmacology in the adolescent oncology patient. J Clin Oncol 2010;28:4790-4799.
  27. Gramatges MM, Rabin KR: The adolescent and young adult with cancer: state of the art - acute leukemias. Curr Oncol Rep 2013;15:317-324.
  28. Vriens MR, Moses W, Weng J, Peng M, Griffin A, Bleyer A, et al: Clinical and molecular features of papillary thyroid cancer in adolescents and young adults. Cancer 2011;117:259-267.
  29. Casanova M, Bisogno G, Gandola L, Cecchetto G, Di Cataldo A, Basso E, et al; Rare Tumors in Pediatric Age Group: A prospective protocol for nasopharyngeal carcinoma in children and adolescents: the Italian rare tumors in pediatric age (TREP) project. Cancer 2012;118:2718-2725.
  30. Daniotti M, Ferrari A, Frigerio S, Casieri P, Miselli F, Zucca E, et al: Cutaneous melanoma in childhood and adolescence shows frequent loss of INK4A and gain of KIT. J Invest Dermatol 2009;129:1759-1768.
  31. Chan JK, Urban R, Cheung MK, Osann K, Shin JY, Husain A, et al: Ovarian cancer in younger vs older women: a population-based analysis. Br J Cancer 2006;95:1314-1320.
  32. Tricoli JV, Seibel NL, Blair DG, Albritton K, Hayes-Lattin B: Unique characteristics of adolescent and young adult acute lymphoblastic leukemia, breast cancer, and colon cancer. J Natl Cancer Inst 2011;103:628-635.
  33. Collinson K, Murray MJ, Orsi NM, Cummings M, Shipley J, Joffe JK, et al: Age-related biological features of germ cell tumors. Genes Chromosomes Cancer 2014;53:215-227.
  34. Kohsaka S, Shukla N, Ameur N, Ito T, Ng CK, Wang L, et al: A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations. Nat Genet 2014;46:595-600.
  35. Kelly D, Pearce S, Mulhall A: ‘Being in the same boat': ethnographic insights into an adolescent cancer unit. Int J Nurs Stud 2004;41:847-857.
  36. De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D, et al; EUROCARE-5 Working Group: Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5 - a population-based study. Lancet Oncol 2014;15:23-34.
  37. National Cancer Peer Review Programme: Manual for cancer services - teenage and young adult measures. England, National Peer Review Programme, 2014.
  38. Erikson EH: Identity: Youth and Crisis. New York, Norton Company, 1968.
  39. Office for National Statistics: Large increase in 20- to 34-year-olds living with parents since 1996 2014. http://www.ons.gov.uk/ons/rel/family-demography/young-adults-living-with-parents/2013/sty-young-adults.html (cited November 1, 2015).
  40. Iacovou M: Leaving Home: Independence, Togetherness and Income in Europe. New York, United Nations Department of Economic and Social Affairs, 2011.
  41. Stark D, Bowen D, Dunwoodie E, Feltbower R, Johnson R, Moran A, et al: Survival patterns in teenagers and young adults with cancer in the United Kingdom: comparisons with younger and older age groups. Eur J Cancer 2015;51:2643-2654.
  42. Smith S: Adolescent units-an evidence-based approach to quality nursing in adolescent care. Eur J Oncol Nurs 2004;8:20-29.
  43. Marris S, Morgan S, Stark D: ‘Listening to patients': what is the value of age-appropriate care to teenagers and young adults with cancer? Eur J Cancer Care (Engl) 2011;20:145-151.
  44. Olsen PR, Harder I: Caring for teenagers and young adults with cancer: a grounded theory study of network-focused nursing. Eur J Oncol Nurs 2011;15:152-159.
  45. Morgan S, Davies S, Palmer S, Plaster M: Sex, drugs, and rock ‘n' roll: caring for adolescents and young adults with cancer. J Clin Oncol 2010;28:4825-4830.
  46. Leonard RC, Gregor A, Coleman RE, Lewis I: Strategy needed for adolescent patients with cancer. BMJ 1995;311:387.
  47. Stark D, Lewis I: Improving outcomes for teenagers and young adults (TYA) with cancer. Klin Padiatr 2013;225:331-334.
  48. Clic-Sargent. A long way from home - the impact of travel on children and young people with cancer. London, December 2010.
  49. Coad J: Teenage Cancer Trust North West Pilot Evaluation: Coventry University. 2015. http://www.coventry.ac.uk/research/research-directories/current-projects/2015/teenage-cancer-trust-north-west-pilot-evaluation/ (accessed November 20, 2015).
  50. Goyal S, Roscoe J, Ryder WD, Gattamaneni HR, Eden TO: Symptom interval in young people with bone cancer. Eur J Cancer 2004;40:2280-2286.
  51. Martin S, Ulrich C, Munsell M, Taylor S, Lange G, Bleyer A: Delays in cancer diagnosis in underinsured young adults and older adolescents. Oncologist 2007;12:816-824.
  52. Desandes E, Bonnay S, Berger C, Brugieres L, Demeocq F, Laurence V, et al: Pathways of care for adolescent patients with cancer in France from 2006 to 2007. Pediatr Blood Cancer 2012;58:924-929.
  53. Veneroni L, Mariani L, Lo Vullo S, Favini F, Catania S, Vajna de Pava M, et al: Symptom interval in pediatric patients with solid tumors: adolescents are at greater risk of late diagnosis. Pediatr Blood Cancer 2013;60:605-610.
  54. Fern LA, Birch R, Whelan J, Cooke M, Sutton S, Neal RD, et al: Why can't we improve the timeliness of cancer diagnosis in children, teenagers, and young adults? BMJ 2013;347:f6493.
  55. Lyratzopoulos G, Neal RD, Barbiere JM, Rubin GP, Abel GA: Variation in number of general practitioner consultations before hospital referral for cancer: findings from the 2010 national cancer patient experience survey in England. Lancet Oncol 2012;13:353-365.
  56. Dommett RM, Redaniel MT, Stevens MC, Hamilton W, Martin RM: Features of cancer in teenagers and young adults in primary care: a population-based nested case-control study. Br J Cancer 2013;108:2329-2333.
  57. Forbes LJ, Simon AE, Warburton F, Boniface D, Brain KE, Dessaix A, et al; International Cancer Benchmarking Partnership Module 2 Working Group: Differences in cancer awareness and beliefs between Australia, Canada, Denmark, Norway, Sweden and the UK (the international cancer benchmarking partnership): do they contribute to differences in cancer survival? Br J Cancer 2013;108:292-300.
  58. Rose PW, Rubin G, Perera-Salazar R, Almberg SS, Barisic A, Dawes M, et al; CBP Module 3 Working Group; ICBP Module 3 Working Group: Explaining variation in cancer survival between 11 jurisdictions in the international cancer benchmarking partnership: a primary care vignette survey. BMJ Open 2015;5:e007212.
  59. Jensen H, Torring ML, Olesen F, Overgaard J, Fenger-Gron M, Vedsted P: Diagnostic intervals before and after implementation of cancer patient pathways - a GP survey and registry based comparison of three cohorts of cancer patients. BMC Cancer 2015;15:308.
  60. Ingeman ML, Christensen MB, Bro F, Knudsen ST, Vedsted P: The Danish cancer pathway for patients with serious non-specific symptoms and signs of cancer - a cross-sectional study of patient characteristics and cancer probability. BMC Cancer 2015;15:421.
  61. Larsen MB, Hansen RP, Hansen DG, Olesen F, Vedsted P: Secondary care intervals before and after the introduction of urgent referral guidelines for suspected cancer in Denmark: a comparative before-after study. BMC Health Serv Res 2013;13:348.
  62. Livestrong Foundation Report Committee: Livestrong Young Adult Alliance Implementation Plan. Austin, Livestrong, 2014.
  63. Livestrong: Closing the Gap: A Strategic Plan. Livestrong, 2007.
  64. Fern LA, Stark DP, Phillips B, Morgan S, Azzim A, Gibson F: Benchmarking Teenage and Young Adult Cancer Professional Developments Across Europe: A Delphi Survey. Amsterdam, European Cancer Congress, 2013.
  65. Smith S: A Blueprint of Care for Teenagers and Young Adults with Cancer. London, 2013. http://www.teenage​cancertrust.org/workspace/documents/Blueprint-of-care.pdf.
  66. General Medical Council: Curriculum for Specialty Training in Medical Oncology. 2010. http://www.gmc-uk.org/Medical_Oncology_curriculum_2010.pdf_32731045.pdf.
  67. Inaugural International Adolescent and Young Adult Oncology Congress. Sydney, 2015. http://youthcancerevent.com.au/ayacongress/home (cited January 1, 2016).
  68. EORTC: SPECTA - Screening Patients for Efficient Clinical Trial Access. Brussels, EORTC, 2015.
  69. ESMO: European Society for Medical Oncology, 2013. http://www.esmo.org/About-Us/Who-We-Are/Educational-Committee/Educational-Committee-Major-Achievements (cited January 1, 2016).
  70. SIOP-E: SIOP-E Strategic Plan 2015-2020, 2015. http://www.siope.eu/2015/10/05/3505/.
  71. Thomas DM, Albritton KH, Ferrari A: Adolescent and young adult oncology: an emerging field. J Clin Oncol 2010;28:4781-4782.
  72. Bleyer A, Siegel SE, Coccia PF, Stock W, Seibel NL: Children, adolescents, and young adults with leukemia: the empty half of the glass is growing. J Clin Oncol 2012;30:4037-4038; author reply 4038-4039.
  73. Whelan J, Barber J, Feltbower R, Fern L, Gibson F, Hooker L, Lerner M, Millington H, Moran A, Morris S, O'Hara C, Pearce S, Raine R, Stark D, Taylor R: Do Specialist Cancer Services for Teenagers and Young Adults (TYA) Add Value? NIHR, 2012.
  74. Smith AW, Bellizzi KM, Keegan TH, Zebrack B, Chen VW, Neale AV, et al: Health-related quality of life of adolescent and young adult patients with cancer in the United States: the adolescent and young adult health outcomes and patient experience study. J Clin Oncol 2013;31:2136-2145.
  75. Baxter NN, Daly C, Gupta S, Pole JD, Sutradhar R, Greenberg ML, et al: The initiative to maximize progress in adolescent and young adult cancer therapy (IMPACT) cohort study: a population-based cohort of young Canadians with cancer. BMC Cancer 2014;14:805.

Article / Publication Details

First-Page Preview
Abstract of Cross-Cutting Issues

Published online: September 05, 2016
Cover Date: 2016

Number of Print Pages: 15
Number of Figures: 6
Number of Tables: 6

ISBN: 978-3-318-05911-3 (Print)
eISBN: 978-3-318-05912-0 (Online)


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.